Rare Diseases projects are listed in alphabetical order in three categories: Open for recruitment; Coming soon; and Closed to recruitment. All groups are available for recall studies.
Each project in the BioResource - Rare Diseases study has it's own project specific recruitment criteria (inclusion/exclusion) which are available to view via the hyperlinks below for each open rare disease project.
Information on this page will be updated when projects open. If you have any questions or would like to recruit to any of our projects please email rarediseases@bioresource.nihr.ac.uk
Open for recruitment
Institution abbreviations are at the end of the Tables |
||
Project Code |
Rare disease project |
Lead Institute |
RDC-ACH |
Newcastle |
|
RDC-AAT |
Birmingham |
|
RDC-AOD |
Cambridge |
|
RDC-AMC |
Birmingham |
|
RDC-ATG |
Cambridge |
|
RDC-AIH |
Newcastle |
|
RDC-AIV |
Leeds |
|
RDC-ADP |
UCLH |
|
RDC-BCR |
Moorfields |
|
RDC-BPD |
Cambridge |
|
RDC-CSV |
Cambridge |
|
RDC-CHG |
Birmingham |
|
RDC-CRD |
GSTT/Manchester |
|
RDC-CIL |
UCLH |
|
RDC-CHI |
Manchester |
|
RDC-CTL |
Birmingham |
|
RDC-DYS |
UCLH |
|
RDC-FIP |
Manchester |
|
RDC-GCA |
Leeds |
|
RDC-HBP |
GSTT/UCLH |
|
RDC-HCP |
Haemophilia Centres Project (recruits through BPD) |
See BPD |
RDC-HAE |
Barts |
|
RDC-HCD |
Newcastle |
|
RDC-HXR |
Moorfields |
|
RDC-IAN |
Leicester |
|
RDC-IMP |
Southampton |
|
|
Inheritable Factor XI Deficiency (recruits through BPD) |
See BPD |
RDC-ION |
Cambridge/Moorfields |
|
RDC-IRD |
Moorfields |
|
RDC-ICP |
KCL/GSTT |
|
RDC-JSC |
Leeds |
|
RDC-PMG |
UCLH |
|
RDC-MNP |
Manchester |
|
RDC-ECT |
Multiple Endocrine Neoplasia Type 1 and Pancreatic Neuroendocrine Tumours |
Oxford |
RDC-MMT |
Cambridge |
|
RDC-MSA |
UCLH |
|
RDC-NRC |
GSTT |
|
RDC-NF1 |
Manchester |
|
RDC-NF2 |
Manchester |
|
RDC-MGR |
Birmingham |
|
RDC-MAC |
Ocular Maldevelopment: Microphthalmia, Anophthalmia and Ocular Coloboma |
Moorfields |
RDC-OCA |
Southampton |
|
RDC-POD |
Birmingham |
|
RDC-PND |
Cambridge |
|
RDC-CKD |
GSTT/KCL |
|
RDC-PBC |
Cambridge |
|
RDC-PID |
Cambridge |
|
RDC-PSC |
Birmingham |
|
RDC-PSJ |
Newcastle |
|
RDC-IND |
Cambridge |
|
RDC-BCA |
Refractoriness First-line Treatment for Blood Cell Autoimmunity |
Imperial/Leeds |
RDC-SAP |
SAPHO Syndrome (Synovitis, Acne, Pustulosis, Hyperostosis, Osteitis) |
Cambridge |
RDC-SOD |
UCLH |
|
RDC-SHG |
GSTT |
|
RDC-SMD |
Oxford |
|
RDC-SAD |
Leeds |
|
RDC-SSC |
Leeds |
|
RDC-TTA |
UCLH |
|
RDC-TUS |
Manchester |
|
RDC-PDC |
Birmingham |
|
RDC-WOL |
Birmingham |
Coming soon
Institution abbreviations are at the end of the Tables
Project Code |
Rare disease project |
Lead Institute |
RDC-ACS |
Acute Coronary Syndromes: SCAD, CAE and FMD |
Leicester |
RDC-ABP |
Alloimmune Blood Disorders of Pregnancy |
Cambridge |
RDC-CYS |
Cystinosis |
GSTT |
RDC-MBD |
Monogenic Beta-cell Diabetes |
Exeter |
RDC-PCD |
Primary Ciliary Dyskinesia |
Leeds |
RDC-AND |
Rare Autoimmune Neurological Disease |
Cambridge |
|
Renal Systemic Lupus Erythematosus |
Recruitment through the IMID BioResource |
RDC-RCM |
Ring Chromosome Mutations |
Patient group |
Closed to recruitmentInstitution abbreviations are at the end of the Tables |
||
Project Code |
Rare disease project |
Lead Institute |
AHU |
Atypical Haemolytic Uraemic Syndrome |
Newcastle |
ATK |
Autosomal Dominant Tubulointerstitial Kidney Diseases |
Cambridge |
EDS |
Ehlers-Danlos Syndrome |
Imperial |
HCM |
Hypertrophic Cardiomyopathy |
Oxford |
MM |
Malignant Mesothelioma |
GSTT |
NPD |
Neuropathic Pain Disorders |
Oxford |
NGC |
Next Generation Children |
Cambridge |
PAH |
Pulmonary Arterial Hypertension |
Cambridge/Papworth |
SPEED |
Specialist Pathology: Evaluating Exomes in Diagnostics |
Cambridge |
SNS |
Steroid Resistant Nephrotic Syndrome |
GSTT |
Abbreviations
GSTT: Guy's and St Thomas' NHS Foundation Trust
KCL: King's College London
Moorfields: Moorfields Eye Hospital NHS Foundation Trust
UCLH: University College London Hospitals NHS Foundation Trust